Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 460321 - 460340 out of 495680 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Switzerland | (L01FE02) panitumumab | Vectibix, Inf Konz 100 mg/5ml, Durchstf 5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FE02) panitumumab | Vectibix, Inf Konz 400 mg/20ml, Durchstf 20 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FF05) atezolizumab | Tecentriq, Inf Konz 1200 mg/20ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RochePharma(Schweiz)AG |
| Switzerland | (L01FG01) bevacizumab | Avastin, Inf Konz 100 mg/4ml, Vial 4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RochePharma(Schweiz)AG |
| Switzerland | (L01FG01) bevacizumab | Avastin, Inf Konz 400 mg/16ml, Vial 16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RochePharma(Schweiz)AG |
| Switzerland | (L01FG01) bevacizumab | Bevacizumab-Teva, Inf Konz 100 mg/4ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaAG |
| Switzerland | (L01FG01) bevacizumab | Bevacizumab-Teva, Inf Konz 400 mg/16ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaAG |
| Switzerland | (L01FG01) bevacizumab | Mvasi, Inf Konz 100 mg/4ml, Durchstf 4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FG01) bevacizumab | Mvasi, Inf Konz 400 mg/16ml, Durchstf 16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FG01) bevacizumab | Oyavas, Inf Konz 100 mg/4ml, Durchstf 4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | SpirigHealthCareAG |
| Switzerland | (L01FG01) bevacizumab | Oyavas, Inf Konz 400 mg/16ml, Durchstf 16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | SpirigHealthCareAG |
| Switzerland | (L01FG01) bevacizumab | Vegzelma, Inf Konz 100 mg/4ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | iQoneHealthcareSwitzerlandSA |
| Switzerland | (L01FG01) bevacizumab | Vegzelma, Inf Konz 400 mg/16ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | iQoneHealthcareSwitzerlandSA |
| Switzerland | (L01FG01) bevacizumab | Zirabev, Inf Konz 100 mg/4ml, Vial 4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerAG |
| Switzerland | (L01FG01) bevacizumab | Zirabev, Inf Konz 400 mg/16ml, Vial 16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerAG |
| Switzerland | (L01FX04) ipilimumab | Yervoy, Inf Konz 200 mg/40ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibbSA |
| Switzerland | (L01FX04) ipilimumab | Yervoy, Inf Konz 50 mg/10ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibbSA |
| Switzerland | (L01FX07) blinatumomab | Blincyto, Trockensub, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenSwitzerlandAG |
| Switzerland | (L01FX17) sacituzumab govitecan | Trodelvy, Trockensub 180 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Triple Negative Breast Neoplasms | GileadSciencesSwitzerlandSàrl |
| Switzerland | (L01FX25) mosunetuzumab | Lunsumio, Inf Konz 1 mg/ml, Durchstf 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | RochePharma(Schweiz)AG |
Pages
